在使用直接作用的口服抗凝剂方面还没有解决的问题
1Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Expert review of cardiovascular therapy
|October 14, 2023
概括
直接口服抗凝剂 (DOACs) 简化了抗凝作用,但具有局限性. 新兴的XIa因子抑制剂可能提供更安全的替代品,等待进一步的临床试验以确定有效性和安全性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
- 血液学 血液学 血液学
背景情况:
- 直接口服抗凝剂 (DOACs) 向血栓或XA因子,简化了抗凝治疗.
- 与传统的维生素K抗剂 (VKA) 不同,DOACs在没有常规监测的情况下以固定的剂量给予.
研究的目的:
- 讨论在最佳使用当前的DOACs未解决的问题.
- 探索新的抗凝剂开发,专注于XIa因子 (FXIa) 抑制剂作为潜在的更安全的替代品.
主要方法:
- 关于DOACs和新兴抗凝固剂的当前文献的综述.
- 对抗凝血疗法的临床应用,局限性和安全性概况的分析.
主要成果:
- DOAC 已经扩大了抗凝剂的使用,但不适合所有患者 (例如,机械心脏门,抗脂综合征).
- 关于出血和成本的担忧仍然是DOAC使用的障碍.
- FXIa 抑制剂显示出提高安全性的潜力,但需要进行大规模试验.
结论:
- 虽然DOACs已经彻底改变了抗凝药,但特定的患者群体需要替代疗法.
- FXIa 抑制剂代表着有希望的下一代抗凝剂,正在等待强有力的临床验证.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
726
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
726
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
538
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
538
Disorders of Hemostasis
968
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
968
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10


